BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Policy

  FDA Plans Ahead for COVID-19 Mutations with Booster Shot Guidance

  The U.S. FDA issued new guidance for vaccine makers as it is preparing for the possibility of needing to approve COVID-19 booster shots against variants of the SARS-CoV-2 virus.

  February 23, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Regeneron and Sanofi Collab Picks Up Third FDA Drug Approval

  On Monday, the companies announced their checkpoint inhibitor Libtayo (cemiplimab-rwlc) won Food and Drug Administration approval for lung cancer.

  February 23, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  GRAIL and Quest Seek to Advance Multi-Cancer Early Detection Blood Test

  Cancer detection company GRAIL has entered into an agreement with Quest Diagnostics that sees Quest providing phlebotomy services to support GRAIL’s multi-cancer early detection blood test Galleri™.

  February 23, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Genetown

  Top 10 Biopharma Companies in Massachusetts to Receive NIH Funding in 2020

  Biopharma companies may receive NIH funding, but generally, not to the extent that academia does. However, the Genetown Hotbed has several biopharma companies that received significant funds from the NIH in 2020. Here’s a look at the top 10.

  February 23, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  NASH Failure Fallout Continues for Intercept with CMO Resignation

  Three months after Chief Executive Officer Mark Pruzanski exited Intercept, the company’s chief medical officer is also leaving.

  February 23, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  2021 Biopharma Update on the Novel Coronavirus: February 23

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 23, 2021.

  February 23, 2021

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Deals

  Catalent Expands Plasmid Capabilities with Delphi Acquisition

  CDMO Catalent continues its push to the top with yet another acquisition. Buying out Delphi Genetics, the manufacturing company can now add plasmid DNA production to its growing list of offerings.

  February 23, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Business

  Money on the Move: February 17-23

  Life sciences companies across the globe are raking in investment dollars to advance drug programs.

  February 23, 2021

   · 

  5 min read

   · 

  Kate Goodwin
• 

  Genetown

  70% Drop in COVID-19 Cases in UK Analyses After Just One Pfizer Shot

  Public Health England (PHE) published real-world analyses of people in the UK who had received the first shot of the Pfizer-BioNTech COVID-19 vaccine.

  February 23, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Pharm Country

  Pfizer Accused of Holding Some Countries to “Ransom” Over COVID-19 Negotiations

  Pfizer has been accused of bullying governments in Latin America over coronavirus disease 2019 (COVID-19) vaccine negotiations, a recent investigative article revealed.

  February 23, 2021

   · 

  3 min read

   · 

  Brandon May